Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 13Phase 1/2 6Phase 3 3Phase 2/3 2Phase 4 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Sarcoma 1Neoplasm Metastasis 1Carcinoma 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Interventional × capmatinib × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT04427072 2025-05-16

GeoMETry-III

Novartis

Phase 3 Terminated
22 enrolled 22 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04816214 2024-03-05

GEOMETRY-E

Novartis

Phase 3 Terminated
6 enrolled 20 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡